{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:24:56Z","timestamp":1793157896121,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1038\/s41397-020-00187-4","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T17:23:20Z","timestamp":1600795400000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["HLA-B*39:01:01 is a novel risk factor for antithyroid drug-induced agranulocytosis in Japanese population"],"prefix":"10.1038","volume":"21","author":[{"given":"Saya","family":"Nakakura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Hosomichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ituro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-1159","authenticated-orcid":false,"given":"Hirofumi","family":"Nakaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"187_CR1","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","volume":"343","author":"AP Weetman","year":"2000","unstructured":"Weetman AP. Graves\u2019 disease. N Engl J Med. 2000;343:1236\u201348.","journal-title":"N Engl J Med"},{"key":"187_CR2","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJM198411223112106","volume":"311","author":"DS Cooper","year":"1984","unstructured":"Cooper DS. Antithyroid drugs. N Engl J Med. 1984;311:1353\u201362.","journal-title":"N Engl J Med"},{"key":"187_CR3","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1210\/jc.2013-2569","volume":"98","author":"H Nakamura","year":"2013","unstructured":"Nakamura H, Miyauchi A, Miyawaki N, Imagawa J. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab. 2013;98:4776\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"187_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40268-017-0172-1","volume":"17","author":"N Vicente","year":"2017","unstructured":"Vicente N, Cardoso L, Barros L, Carrilho F. Antithyroid drug-induced agranulocytosis: state of the art on diagnosis and management. Drugs R D 2017;17:91\u20136.","journal-title":"Drugs R D"},{"key":"187_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8633","volume":"6","author":"PL Chen","year":"2015","unstructured":"Chen PL, Shih SR, Wang PW, Lin YC, Chu CC, Lin JH, et al. Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Nat Commun. 2015;6:7633.","journal-title":"Nat Commun"},{"key":"187_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cpt.309","volume":"99","author":"CL Cheung","year":"2016","unstructured":"Cheung CL, Sing CW, Tang CS, Cheng VK, Pirmohamed M, Choi CH, et al. HLA-B*38:02:01 predicts carbimazole\/methimazole-induced agranulocytosis. Clin Pharm Ther. 2016;99:555\u201361.","journal-title":"Clin Pharm Ther"},{"key":"187_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12350-2","volume":"7","author":"Y He","year":"2017","unstructured":"He Y, Zheng J, Zhang Q, Hou P, Zhu F, Yang J, et al. Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern China. Sci Rep. 2017;7:11950.","journal-title":"Sci Rep"},{"key":"187_CR8","doi-asserted-by":"publisher","first-page":"7965346","DOI":"10.1155\/2018\/7965346","volume":"2018","author":"MP Thao","year":"2018","unstructured":"Thao MP, Tuan PVA, Linh LGH, Van Hoang L, Hen PH, Hoa LT, et al. Association of HLA-B\u221738:02 with antithyroid drug-induced agranulocytosis in Kinh Vietnamese patients. Int J Endocrinol. 2018;2018:7965346.","journal-title":"Int J Endocrinol"},{"key":"187_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S2213-8587(16)00113-3","volume":"4","author":"P Hallberg","year":"2016","unstructured":"Hallberg P, Eriksson N, Iba\u00f1ez L, Bondon-Guitton E, Kreutz R, Carvajal A, et al. Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. Lancet Diabetes Endocrinol. 2016;4:507\u201316.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"187_CR10","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1111\/bcp.13989","volume":"85","author":"WT Chen","year":"2019","unstructured":"Chen WT, Chi CC. Associations of HLA genotypes with antithyroid drug-induced agranulocytosis: a systematic review and meta-analysis of pharmacogenomics studies. Br J Clin Pharmacol. 2019;85:1878\u201387.","journal-title":"Br J Clin Pharmacol"},{"key":"187_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.7326\/0003-4819-124-5-199603010-00005","volume":"124","author":"H Tamai","year":"1996","unstructured":"Tamai H, Sudo T, Kimura A, Mukuta T, Matsubayashi S, Kuma K, et al. Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease. Ann Intern Med. 1996;124:490\u20134.","journal-title":"Ann Intern Med"},{"key":"187_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/jhg.2015.102","volume":"60","author":"K Hosomichi","year":"2015","unstructured":"Hosomichi K, Shiina T, Tajima A, Inoue I. The impact of next-generation sequencing technologies on HLA research. J Hum Genet. 2015;60:665\u201373.","journal-title":"J Hum Genet"},{"key":"187_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41588-018-0336-0","volume":"51","author":"J Hirata","year":"2019","unstructured":"Hirata J, Hosomichi K, Sakaue S, Kanai M, Nakaoka H, Ishigaki K, et al. Genetic and phenotypic landscape of the major histocompatibilty complex region in the Japanese population. Nat Genet. 2019;51:470\u201380.","journal-title":"Nat Genet"},{"key":"187_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.humimm.2016.01.020","volume":"77","author":"J Robinson","year":"2016","unstructured":"Robinson J, Soormally AR, Hayhurst JD, Marsh SGE. The IPD-IMGT\/HLA database\u2014new developments in reporting HLA variation. Hum Immunol. 2016;77:233\u20137.","journal-title":"Hum Immunol"},{"key":"187_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-355","volume":"14","author":"K Hosomichi","year":"2013","unstructured":"Hosomichi K, Jinam TA, Mitsunaga S, Nakaoka H, Inoue I. Phase-defined complete sequencing of the HLA genes by next-generation sequencing. BMC Genom. 2013;14:355.","journal-title":"BMC Genom"},{"key":"187_CR16","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler Transform. Bioinformatics. 2009;25:1754\u201360.","journal-title":"Bioinformatics"},{"key":"187_CR17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"187_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491\u20138.","journal-title":"Nat Genet"},{"key":"187_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ajhg.2009.01.005","volume":"84","author":"BL Browning","year":"2009","unstructured":"Browning BL, Browning SR. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am J Hum Genet. 2009;84:210\u201323.","journal-title":"Am J Hum Genet"},{"key":"187_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/jhg.2009.95","volume":"54","author":"H Nakaoka","year":"2009","unstructured":"Nakaoka H, Inoue I. Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner\u2019s curse. J Hum Genet. 2009;54:615\u201323.","journal-title":"J Hum Genet"},{"key":"187_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101\u201329.","journal-title":"Biometrics"},{"key":"187_CR22","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"187_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153\u201360.","journal-title":"Evid Based Ment Health"},{"key":"187_CR24","doi-asserted-by":"publisher","first-page":"D784","DOI":"10.1093\/nar\/gku1166","volume":"43","author":"FF Gonz\u00e1lez-Galarza","year":"2015","unstructured":"Gonz\u00e1lez-Galarza FF, Takeshita LY, Santos EJ, Kempson F, Maia MH, da Silva AL, et al. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 2015;43:D784\u20138.","journal-title":"Nucleic Acids Res"},{"key":"187_CR25","doi-asserted-by":"publisher","first-page":"E379","DOI":"10.1210\/jc.2013-2841","volume":"99","author":"S Ueda","year":"2014","unstructured":"Ueda S, Oryoji D, Yamamoto K, Noh JY, Okamura K, Noda M, et al. Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J Clin Endocrinol Metab. 2014;99:E379\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"187_CR26","doi-asserted-by":"publisher","first-page":"e0216941","DOI":"10.1371\/journal.pone.0216941","volume":"14","author":"DH Shin","year":"2019","unstructured":"Shin DH, Baek IC, Kim HJ, Choi EJ, Ahn M, Jung MH, et al. HLA alleles, especially amino-acid signatures of HLA-DPB1, might contribute to the molecular pathogenesis of early-onset autoimmune thyroid disease. PLoS ONE 2019;14:e0216941.","journal-title":"PLoS ONE"},{"key":"187_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/tan.13143","volume":"90","author":"DV Nguyen","year":"2017","unstructured":"Nguyen DV, Vidal C, Chi HC, Do NTQ, Fulton R, Li J, et al. A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01\/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions. HLA. 2017;90:335\u201342.","journal-title":"HLA"},{"key":"187_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.eplepsyres.2017.05.015","volume":"135","author":"Q Wang","year":"2017","unstructured":"Wang Q, Sun S, Xie M, Zhao K, Li X, Zhao Z. Association between the HLA-B alleles and carbamazepine-induced SJS\/TEN: A meta-analysis. Epilepsy Res. 2017;135:19\u201328.","journal-title":"Epilepsy Res"},{"key":"187_CR29","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1093\/hmg\/ddt266","volume":"22","author":"YJ Kim","year":"2013","unstructured":"Kim YJ, Kim HY, Lee JH, Yu SJ, Yoon JH, Lee HS, et al. A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum Mol Genet. 2013;22:4233\u20138.","journal-title":"Hum Mol Genet"},{"key":"187_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/hep.27794","volume":"62","author":"DK Jiang","year":"2015","unstructured":"Jiang DK, Ma XP, Yu H, Cao G, Ding DL, Chen H, et al. Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B. Hepatology. 2015;62:118\u201328.","journal-title":"Hepatology"},{"key":"187_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41435-017-0004-x","volume":"20","author":"JG Shin","year":"2019","unstructured":"Shin JG, Cheong HS, Kim JY, Lee JH, Yu SJ, Yoon JH, et al. Identification of additional EHMT2 variant associated with the risk of chronic hepatitis B by GWAS follow-up study. Genes Immun. 2019;20:1\u20139.","journal-title":"Genes Immun"},{"key":"187_CR32","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMoa0706135","volume":"358","author":"S Mallal","year":"2008","unstructured":"Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;358:568\u201379.","journal-title":"N Engl J Med"},{"key":"187_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/tan.13183","volume":"91","author":"AJ Redwood","year":"2018","unstructured":"Redwood AJ, Pavlos RK, White KD, Phillips EJ. HLAs: key regulators of T-cell-mediated drug hypersensitivity. HLA. 2018;91:3\u201316.","journal-title":"HLA"},{"key":"187_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11147","volume":"486","author":"PT Illing","year":"2012","unstructured":"Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature. 2012;486:554\u20138.","journal-title":"Nature"},{"key":"187_CR35","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.1073\/pnas.1207934109","volume":"109","author":"DA Ostrov","year":"2012","unstructured":"Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, et al. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci USA. 2012;109:9959\u201364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"187_CR36","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","volume":"129","author":"CY Wei","year":"2012","unstructured":"Wei CY, Chung WH, Huang HW, Chen YT, Hung SI. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol. 2012;129:1562\u20139.e5.","journal-title":"J Allergy Clin Immunol"},{"key":"187_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11396-2","volume":"10","author":"RY Pan","year":"2019","unstructured":"Pan RY, Chu MT, Wang CW, Lee YS, Lemonnier F, Michels AW, et al. Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Nat Commun. 2019;10:3569.","journal-title":"Nat Commun"},{"key":"187_CR38","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/cea.12184","volume":"43","author":"J Yun","year":"2013","unstructured":"Yun J, Mattsson J, Schnyder K, Fontana S, Largiad\u00e8r CR, Pichler WJ, et al. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response. Clin Exp Allergy. 2013;43:1246\u201355.","journal-title":"Clin Exp Allergy"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41397-020-00187-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-020-00187-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-020-00187-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T19:19:42Z","timestamp":1632251982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-020-00187-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["187"],"URL":"https:\/\/doi.org\/10.1038\/s41397-020-00187-4","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}